About: biomedicines

IMI chief: ‘We need to learn how to share data in a safe and ethical manner’
Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.
Regulators pave way for new wave of biosimilar drugs in Europe
European regulators have cleared the way for the first serious threat to the makers of multibillion-euro biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis.